Literature DB >> 25293343

Primary tumor size predicts pathologic findings in the retroperitoneal lymph nodes in patients with paratesticular rhabdomyosarcoma.

Shaheen Alanee1, Bradley Holland, Danuta Dynda, Onsi Kamel, Sabha Ganai.   

Abstract

To determine patient and tumor characteristics that could predict pathologic findings after retroperitoneal lymph node dissection (RPLND) in paratesticular rhabdomyosarcoma (PTRMS), a total of 266 cases of PTRMS diagnosed between 1973 and 2010 were identified from a national database. RPLND dissection was performed in 67 patients, with a mean age of 14.9 years and median survival of 80 months. PTRMS occurred more often on the right side, had embryonal histology, and had an average size of 6.7 cm. Retroperitoneal lymph node (RPLN) metastasis occurred in 40 % (n = 27) of patients. Tumor size and age were strong predictors of finding rhabdomyosarcoma in the retroperitoneal lymph nodes when examined by pathologists. Primary tumors larger than 7 cm in size developing in males 12 years or older had four times more odds of being associated with positive findings on pathologic examinations of the retroperitoneal lymph nodes. Patient race, histology, and tumor laterality were not significant predictors of PTRMS metastasis to the RPLN basin. Patients 12 years or older with PTRMS larger than 7 cm have a significant risk of retroperitoneal lymph nodes involvement with PTRMS. Detailed pathologic examination of the lymph nodes in these patients is recommended.

Entities:  

Mesh:

Year:  2014        PMID: 25293343     DOI: 10.1007/s00428-014-1663-x

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  18 in total

Review 1.  Benign and malignant pediatric scrotal masses.

Authors:  S J Skoog
Journal:  Pediatr Clin North Am       Date:  1997-10       Impact factor: 3.278

2.  Clear cell sarcoma of soft tissue: a retrospective review and analysis of 31 cases treated at Istituto Ortopedico Rizzoli.

Authors:  G Bianchi; C Charoenlap; S Cocchi; N Rani; S Campagnoni; A Righi; T Frisoni; D M Donati
Journal:  Eur J Surg Oncol       Date:  2014-02-02       Impact factor: 4.424

3.  Impact of delay in diagnosis on clinical stage of testicular cancer.

Authors:  G J Bosl; N J Vogelzang; A Goldman; E E Fraley; P H Lange; S H Levitt; B J Kennedy
Journal:  Lancet       Date:  1981-10-31       Impact factor: 79.321

4.  Uterine leiomyosarcomas: tumor size, mitotic index, and biomarkers Ki67, and Bcl-2 identify two groups with different prognosis.

Authors:  Emanuela D'Angelo; Inigo Espinosa; Rola Ali; C Blake Gilks; Matt van de Rijn; Cheng-Han Lee; Jaime Prat
Journal:  Gynecol Oncol       Date:  2011-02-12       Impact factor: 5.482

5.  Lymph node management in patients with paratesticular rhabdomyosarcoma: a population-based analysis.

Authors:  Nguyen D Dang; Phuong-Thanh Dang; Jason Samuelian; Arnold C Paulino
Journal:  Cancer       Date:  2013-06-06       Impact factor: 6.860

6.  Controversies in the management of paratesticular rhabdomyosarcoma: is staging retroperitoneal lymph node dissection necessary for adolescents with resected paratesticular rhabdomyosarcoma?

Authors:  E S Wiener; J R Anderson; J I Ojimba; T E Lobe; C Paidas; R J Andrassy; R B Raney; S J Qualman; S S Donaldson; H M Maurer; M P Link; W M Crist; H E Grier
Journal:  Semin Pediatr Surg       Date:  2001-08       Impact factor: 2.754

7.  Clinicopathologic factors and adjuvant treatment effects on survival in adult head and neck synovial cell sarcoma.

Authors:  Matthew G Crowson; Ian Lalich; Michael G Keeney; Joaquin J Garcia; Daniel L Price
Journal:  Head Neck       Date:  2014-04-03       Impact factor: 3.147

8.  Retroperitoneal node biopsy in paratesticular rhabdomyosarcoma.

Authors:  E S Wiener; W Lawrence; D Hays; T E Lobe; R Andrassy; S Donaldson; W Crist; W Newton; J Johnson; E Gehan
Journal:  J Pediatr Surg       Date:  1994-02       Impact factor: 2.545

9.  Primary localized rectal/pararectal gastrointestinal stromal tumors: results of surgical and multimodal therapy from the French Sarcoma group.

Authors:  Thanh-Khoa Huynh; Pierre Meeus; Philippe Cassier; Olivier Bouché; Sophie Lardière-Deguelte; Antoine Adenis; Thierry André; Julien Mancini; Olivier Collard; Michael Montemurro; Emmanuelle Bompas; Maria Rios; Nicolas Isambert; Didier Cupissol; Jean-Yves Blay; Florence Duffaud
Journal:  BMC Cancer       Date:  2014-03-05       Impact factor: 4.430

10.  Factors that predict lymph node status in clinical stage T1aN0M0 lung adenocarcinomas.

Authors:  Bo Ye; Ming Cheng; Xiao-Xiao Ge; Jun-Feng Geng; Wang Li; Jian Feng; Ding-Zhong Hu; Heng Zhao
Journal:  World J Surg Oncol       Date:  2014-02-21       Impact factor: 2.754

View more
  4 in total

1.  Demographic and Treatment Variables Influencing Outcome for Localized Paratesticular Rhabdomyosarcoma: Results From a Pooled Analysis of North American and European Cooperative Groups.

Authors:  David O Walterhouse; Donald A Barkauskas; David Hall; Andrea Ferrari; Gian Luca De Salvo; Ewa Koscielniak; Michael C G Stevens; Hélène Martelli; Guido Seitz; David A Rodeberg; Margarett Shnorhavorian; Roshni Dasgupta; John C Breneman; James R Anderson; Christophe Bergeron; Gianni Bisogno; William H Meyer; Douglas S Hawkins; Veronique Minard-Colin
Journal:  J Clin Oncol       Date:  2018-10-23       Impact factor: 44.544

2.  Surgical management of paratesticular rhabdomyosarcoma: A consensus opinion from the Children's Oncology Group, European paediatric Soft tissue sarcoma Study Group, and the Cooperative Weichteilsarkom Studiengruppe.

Authors:  Timothy N Rogers; Guido Seitz; Jörg Fuchs; Helene Martelli; Roshni Dasgupta; Jonathan C Routh; Douglas S Hawkins; Ewa Koscielniak; Gianni Bisogno; David A Rodeberg
Journal:  Pediatr Blood Cancer       Date:  2021-02-01       Impact factor: 3.838

3.  Case Report: Paratesticular Rhabdomyosarcoma.

Authors:  Yiyi Zhu; Ziwei Zhu; Yunyuan Xiao; Zaisheng Zhu
Journal:  Front Oncol       Date:  2021-03-17       Impact factor: 6.244

4.  Impact of local control and surgical lymph node evaluation in localized paratesticular rhabdomyosarcoma: A report from the Children's Oncology Group Soft Tissue Sarcoma Committee.

Authors:  Jonathan C Routh; Roshni Dasgupta; Yueh-Yun Chi; Margarett Shnorhavorian; Jing Tian; David O Walterhouse; John Breneman; Suzanne L Wolden; Carola A Arndt; Douglas S Hawkins; David A Rodeberg
Journal:  Int J Cancer       Date:  2020-07-11       Impact factor: 7.396

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.